Your browser doesn't support javascript.
loading
Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape.
Nsanzabana, Christian; Djalle, Djibrine; Guérin, Philippe J; Ménard, Didier; González, Iveth J.
Afiliación
  • Nsanzabana C; Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland. nsanzabana.christian@gmail.com.
  • Djalle D; Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
  • Guérin PJ; WorldWide Antimalarial Resistance Network, Oxford, UK.
  • Ménard D; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • González IJ; Unité Biologie des Interactions Hôte-Parasite, Institut Pasteur, Paris, France.
Malar J ; 17(1): 75, 2018 Feb 08.
Article en En | MEDLINE | ID: mdl-29422048
ABSTRACT
To limit the spread and impact of anti-malarial drug resistance and react accordingly, surveillance systems able to detect and track in real-time its emergence and spread need to be strengthened or in some places established. Currently, surveillance of anti-malarial drug resistance is done by any of three approaches (1) in vivo studies to assess the efficacy of drugs in patients; (2) in vitro/ex vivo studies to evaluate parasite susceptibility to the drugs; and/or (3) molecular assays to detect validated gene mutations and/or gene copy number changes that are associated with drug resistance. These methods are complementary, as they evaluate different aspects of resistance; however, standardization of methods, especially for in vitro/ex vivo and molecular techniques, is lacking. The World Health Organization has developed a standard protocol for evaluating the efficacy of anti-malarial drugs, which is used by National Malaria Control Programmes to conduct their therapeutic efficacy studies. Regional networks, such as the East African Network for Monitoring Antimalarial Treatment and the Amazon Network for the Surveillance of Antimalarial Drug Resistance, have been set up to strengthen regional capacities for monitoring anti-malarial drug resistance. The Worldwide Antimalarial Resistance Network has been established to collate and provide global spatial and temporal trends information on the efficacy of anti-malarial drugs and resistance. While exchange of information across endemic countries is essential for monitoring anti-malarial resistance, sustainable funding for the surveillance and networking activities remains challenging. The technology landscape for molecular assays is progressing quite rapidly, and easy-to-use and affordable new techniques are becoming available. They also offer the advantage of high throughput analysis from a simple blood spots obtained from a finger prick. New technologies combined with the strengthening of national reference laboratories in malaria-endemic countries through standardized protocols and training plus the availability of a proficiency testing programme, would contribute to the improvement and sustainability of anti-malarial resistance surveillance networks worldwide.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Plasmodium falciparum / Resistencia a Medicamentos / Malaria Falciparum / Pruebas de Sensibilidad Parasitaria / Antimaláricos Tipo de estudio: Guideline / Screening_studies Idioma: En Revista: Malar J Asunto de la revista: MEDICINA TROPICAL Año: 2018 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Plasmodium falciparum / Resistencia a Medicamentos / Malaria Falciparum / Pruebas de Sensibilidad Parasitaria / Antimaláricos Tipo de estudio: Guideline / Screening_studies Idioma: En Revista: Malar J Asunto de la revista: MEDICINA TROPICAL Año: 2018 Tipo del documento: Article País de afiliación: Suiza